Results 1 to 10 of about 5,700 (152)

Oropharyngeal Candidiasis as a Presenting Symptom of Crohn's Disease. [PDF]

Case Rep Gastroenterol, 2020
Oropharyngeal candidiasis is a common condition in immunosuppressed patients. Inflammatory bowel disease (IBD) is a prevalent medical condition which commonly presents with intestinal and extra intestinal manifestations. Crohn’s disease (CD) tends to present more with extraintestinal symptoms.
Sharif M, Saddique MU, Zahid M, Khan D, Bashir T, Murshed K.   +5 more
europepmc   +6 more sources

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis [PDF]

Journal of Fungi (Basel, Switzerland), 2021
The objective of this study was to assess the comparative efficacy and safety of different antifungal agents used for the treatment of oropharyngeal candidiasis (OPC) in adult patients with HIV.
Maharajan M K, Divya Gopinath, Sajesh K Veettil   +2 more
exaly   +4 more sources

Radiation Exposure Perturbs IL-17RA-Mediated Immunity Leading to Changes in Neutrophil Responses That Increase Susceptibility to Oropharyngeal Candidiasis. [PDF]

J Fungi (Basel), 2022
Fungal infections caused by Candida albicans are a serious problem for immunocompromised individuals, including those undergoing radiotherapy for head and neck cancers.
Saul-McBeth J, Dillon J, Launder D, Hickey M, Yi EM, Daboul Y, Biswas P, Salari E, Parsai EI, Conti HR.   +9 more
europepmc   +2 more sources

Severe oropharyngeal candidiasis in an anemic pregnant woman: A case report. [PDF]

Med Mycol Case Rep
Hormonal fluctuations during pregnancy increase susceptibility to Candida infections, typically presenting as vulvovaginal candidiasis, but rarely as oropharyngeal candidiasis.
Quan S, Li H, Li K, Wang X, Xu Y, Gu P.
europepmc   +2 more sources

IκBζ is an essential mediator of immunity to oropharyngeal candidiasis. [PDF]

Cell Host Microbe, 2023
Fungal infections are a global threat; yet, there are no licensed vaccines to any fungal pathogens. Th17 cells mediate immunity to Candida albicans, particularly oropharyngeal candidiasis (OPC), but essential downstream mechanisms remain unclear. In the murine model of OPC, IκBζ (Nfkbiz, a non-canonical NF-κB transcription factor) was upregulated in an
Taylor TC, Coleman BM, Arunkumar SP, Dey I, Dillon JT, Ponde NO, Poholek AC, Schwartz DM, McGeachy MJ, Conti HR, Gaffen SL.   +10 more
europepmc   +3 more sources

Miconazole mucoadhesive tablet for oropharyngeal candidiasis [PDF]

Expert Review of Anti-Infective Therapy, 2011
Oropharyngeal candidiasis is a commonly encountered problem in daily clinical practice. Topical therapies for oropharyngeal candidiasis are considered preferable to systemic therapies in most patient populations. However, traditional topical therapies have limitations including short contact time with the oral mucosa and the need for multiple doses ...
Rajesh Lalla, René Jean Bensadoun
exaly   +3 more sources

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis. [PDF]

Front Microbiol, 2019
Oropharyngeal candidiasis is a common opportunistic mucosal infection of the oral cavity, mainly caused by an overgrowth of Candida albicans. This infection can inhibit nutritional intakes and strongly affect quality of life.
Roselletti E, Sabbatini S, Ballet N, Perito S, Pericolini E, Blasi E, Mosci P, Cayzeele Decherf A, Monari C, Vecchiarelli A.   +9 more
europepmc   +2 more sources

Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis. [PDF]

Life (Basel), 2022
The objective of the study was to compare the efficacy and safety of antifungal agents used in the prevention of oropharyngeal candidiasis among HIV-infected adults.
Rajadurai SG, Maharajan MK, Veettil SK, Gopinath D.   +3 more
europepmc   +2 more sources

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection

HIV/AIDS - Research and Palliative Care, 2010
Jose A VazquezDivision of Infectious Diseases, Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Mucocutaneous candidiasis is frequently one of the f irst signs of human immunodeficiency virus (HIV) infection. Over
José Vazquez
exaly   +2 more sources

Rethinking T cell immunity in oropharyngeal candidiasis [PDF]

Journal of Experimental Medicine, 2009
The disproportionate increase in oropharyngeal candidiasis (OPC) compared with systemic and vaginal candidiasis in female patients with AIDS has been a paradox for almost three decades. New data now show that severe OPC develops in Th17-deficient mice, but not Th1-deficient mice, implicating Th17-induced effector molecules in resistance to oral disease.
Arturo Casadevall
exaly   +3 more sources